发布求助
文献互助 智能选刊 最新文献

Im Fokus Onkologie最新文献

筛选
英文 中文
HCC: Immuntherapie und Antiangiogenese als TACE-Partner 肝癌：免疫疗法和抗血管生成是 TACE 的合作伙伴
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3762-0
F. Klein
{"title":"HCC: Immuntherapie und Antiangiogenese als TACE-Partner","authors":"F. Klein","doi":"10.1007/s15015-024-3762-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3762-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"393 ","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140756747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Immuntherapie beim frühen NSCLC von Nutzen 早期非小细胞肺癌围手术期免疫疗法的益处
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3778-5
B. Schumacher
{"title":"Perioperative Immuntherapie beim frühen NSCLC von Nutzen","authors":"B. Schumacher","doi":"10.1007/s15015-024-3778-5","DOIUrl":"https://doi.org/10.1007/s15015-024-3778-5","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"44 20","pages":"34"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140796424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygener Risikoscore bei Krebs: Bedeutung hängt von der Entität ab 癌症多基因风险评分：意义取决于实体
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3792-7
Claudia Schöllmann
{"title":"Polygener Risikoscore bei Krebs: Bedeutung hängt von der Entität ab","authors":"Claudia Schöllmann","doi":"10.1007/s15015-024-3792-7","DOIUrl":"https://doi.org/10.1007/s15015-024-3792-7","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"124 5","pages":"54"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140793209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Was Methylierung und Mutationen beim Glioblastom bedeuten 甲基化和突变在胶质母细胞瘤中的意义
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3757-x
Marie-Thérèse Weitzl
{"title":"Was Methylierung und Mutationen beim Glioblastom bedeuten","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15015-024-3757-x","DOIUrl":"https://doi.org/10.1007/s15015-024-3757-x","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"154 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140773208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T-Zellen: Mit Base Editing vielleicht auch bei T-Zell-Leukämie möglich CAR-T 细胞：碱基编辑也可用于治疗 T 细胞白血病
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3768-7
B. Fessler
{"title":"CAR-T-Zellen: Mit Base Editing vielleicht auch bei T-Zell-Leukämie möglich","authors":"B. Fessler","doi":"10.1007/s15015-024-3768-7","DOIUrl":"https://doi.org/10.1007/s15015-024-3768-7","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"339 2","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
„Personalisierung und gezielte Therapie weiter vorantreiben“ "推动个性化和靶向治疗"
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3821-6
Petra Ortner
{"title":"„Personalisierung und gezielte Therapie weiter vorantreiben“","authors":"Petra Ortner","doi":"10.1007/s15015-024-3821-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3821-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"176 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140788163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wie sieht die Onkologie in der Zukunft aus? 未来的肿瘤学会是什么样子？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3809-2
Redaktion Facharztmagazine
{"title":"Wie sieht die Onkologie in der Zukunft aus?","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3809-2","DOIUrl":"https://doi.org/10.1007/s15015-024-3809-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140755493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immuntherapie: Keine Angst vor den Nebenwirkungen 免疫疗法：不要害怕副作用
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3805-6
Mascha Pömmerl
{"title":"Immuntherapie: Keine Angst vor den Nebenwirkungen","authors":"Mascha Pömmerl","doi":"10.1007/s15015-024-3805-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3805-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"528 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Das ist neu in der Leitlinie Ösophaguskarzinom 食道癌指南的新内容
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3761-1
E. Oberhofer
{"title":"Das ist neu in der Leitlinie Ösophaguskarzinom","authors":"E. Oberhofer","doi":"10.1007/s15015-024-3761-1","DOIUrl":"https://doi.org/10.1007/s15015-024-3761-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"203 ","pages":"39-43"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140792336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diente Krebs als „Alibi“ für einen Mord? 癌症是谋杀的 "不在场证明 "吗？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3755-z
Lamia Özgör
{"title":"Diente Krebs als „Alibi“ für einen Mord?","authors":"Lamia Özgör","doi":"10.1007/s15015-024-3755-z","DOIUrl":"https://doi.org/10.1007/s15015-024-3755-z","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"153 1","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信